| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Dextromethorphan measurement |
Component |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Product containing dextromethorphan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Dextromethorphan hydrobromide adverse reaction |
Causative agent (attribute) |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Dextromethorphan hydrobromide (substance) |
Is a |
False |
Dextromethorphan (substance) |
Inferred relationship |
Some |
|
| Product containing chlorphenamine and dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Product containing dextromethorphan and guaifenesin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Guaifenesin 600mg m/r/dextromethorphan 30mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 1200mg m/r/dextromethorphan 60mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan (substance) |
Inferred relationship |
Some |
|
| Product containing dextromethorphan and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing dextromethorphan and promethazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing dextromethorphan and doxylamine and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Product containing dextromethorphan and diphenhydramine and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Product containing dextromethorphan and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing dextromethorphan and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Dextromethorphan polistirex 30mg/5mL m/r oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan (substance) |
Inferred relationship |
Some |
|
| Product containing dextromethorphan and triprolidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing dextromethorphan and diphenhydramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing dextromethorphan and menthol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Promethazine 6.25mg/dextromethorphan 15mg 5mL oral syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan (substance) |
Inferred relationship |
Some |
|
| Dextromethorphan polistirex (substance) |
Is a |
False |
Dextromethorphan (substance) |
Inferred relationship |
Some |
|
| Product containing chlorphenamine and dextromethorphan and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Poisoning by dextromethorphan |
Causative agent (attribute) |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Intentional dextromethorphan poisoning |
Causative agent (attribute) |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Accidental dextromethorphan poisoning |
Causative agent (attribute) |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| intoxication par le dextrométhorphane d'intention indéterminée |
Causative agent (attribute) |
False |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing carbinoxamine and dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Dextromethorphan hydrobromide (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
|
| Dextromethorphan polistirex (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 1200mg /dextromethorphan 60mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan (substance) |
Inferred relationship |
Some |
|
| Guaifenesin 600mg /dextromethorphan 30mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan (substance) |
Inferred relationship |
Some |
|
| Dextromethorphan only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Dextromethorphan only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Allergy to dextromethorphan |
Causative agent (attribute) |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Carbinoxamine and dextromethorphan and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Product containing only chlorphenamine and dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Chlorphenamine and dextromethorphan and paracetamol and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Product containing only dextromethorphan and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing only dextromethorphan and promethazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing only dextromethorphan and diphenhydramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing only dextromethorphan and diphenhydramine and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Dextromethorphan and guaifenesin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dextromethorphan and menthol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dextromethorphan and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing only dextromethorphan and phenylephrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing only dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Dextromethorphan and triprolidine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing only dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Dextromethorphan and doxylamine and paracetamol and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Dextromethorphan 7.5 mg oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Dextromethorphan 7.5 mg oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing only dextromethorphan and guaifenesin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Dextromethorphan and promethazine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Brompheniramine- and dextromethorphan- and pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Carbinoxamine and dextromethorphan and pseudoephedrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Product containing only brompheniramine and dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Product containing only brompheniramine and dextromethorphan and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Brompheniramine- and dextromethorphan- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing carbinoxamine and dextromethorphan and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Dextromethorphan-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Product containing dextromethorphan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Product containing dextromethorphan and promethazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Dextromethorphan- and guaifenesin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dextromethorphan in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
1 |
| Product containing only dextromethorphan and paracetamol and promethazine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing only dextromethorphan and paracetamol and promethazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Dextromethorphan- and paracetamol- and promethazine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Dextromethorphan- and paracetamol- and promethazine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely dextromethorphan 2 milligram/1 milliliter and pseudoephedrine hydrochloride 6 milligram/1 milliliter and triprolidine hydrochloride 250 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing precisely dextromethorphan 2 milligram/1 milliliter and pseudoephedrine hydrochloride 6 milligram/1 milliliter and triprolidine hydrochloride 250 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing only dextromethorphan and pseudoephedrine and triprolidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Product containing dextromethorphan and pseudoephedrine and triprolidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Product containing only dextromethorphan and pseudoephedrine and triprolidine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Dextromethorphan- and pseudoephedrine- and triprolidine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
3 |
| Product containing only dextromethorphan and diphenhydramine and levomenthol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing dextromethorphan and diphenhydramine and levomenthol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Dextromethorphan and diphenhydramine and levomenthol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
| Product containing dextromethorphan and diphenhydramine and levomenthol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Dextromethorphan (substance) |
Inferred relationship |
Some |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]